Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours
暂无分享,去创建一个
Xiaojin Shi | T. Seto | H. Takeoka | T. Esaki | T. Kometani | F. Hirai | K. Nosaki | F. Agbo | S. Arita | M. Hamatake | A. Makiyama | Chinatsu Fujimoto